They are awful stats if you are a patient. Prognosis of 7% and even with a chemo and /or radio treatment regime only extending life for a limited period with quite some discomfort for the most part. Sometimes I think an IV morphine pump and a graceful exit around loved ones at home is better. Anyway that's another topic.
If either SRX or OSL can find an in-situ radioactive treatment to halt, regress and or even remove liver tumours (or pancreas, gall bladder, kidney, l&s intestines, etc.) and then overlayed with regenerative treatment to rebuild the organ tissue it would be awesome but I still feel current research approach and trials aren't getting to a decent beta beyond existing treatment regimes.
Again, if, OSL or SRX find a way of treating an aberrant liver condition that ensures no lesser results that through existing treatment but at a lower cost then that will get uptake across various medical communities.
- Forums
- ASX - By Stock
- Impact of Sirflox failure to meet primary end point
They are awful stats if you are a patient. Prognosis of 7% and...
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $45.40M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.1¢ | $92.50K | 7.934M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 4566639 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 7725812 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 4566639 | 0.011 |
13 | 8580000 | 0.010 |
11 | 7629930 | 0.009 |
7 | 10137600 | 0.008 |
15 | 5741677 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 7725812 | 7 |
0.013 | 10456832 | 5 |
0.014 | 5572553 | 9 |
0.015 | 8500000 | 3 |
0.016 | 3785670 | 4 |
Last trade - 16.10pm 07/08/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |